None listed
Conditions
Interventions
Intervention1: AZADIRACHTA INDICA: dose 12 doses
route of administration oral route
frequency 4 times a day
duration 6weeks
Control Intervention1:
AZADIRECHTA INDICA: DRUG POWER 30
DOSE Four times
Sponsors
dr willmar schwabe india
Bharati vidyapeeth homoeopathic medical college and homoeopathic hospital Pune
Eligibility
Inclusion criteria
Inclusion criteria: INCLUSION CRITERIA- 1.Age: 18 – 60 years 2.Both males and females 3.Healthy individuals with no apparent disease and normal unprejudiced. Laboratory parameters during screening 4.Intelligent enough to record carefully the facts, subjective and objective Symptoms generated by the drug during proving. 5.Able to be informed of the nature of the study and willing to give Written informed consent.
Exclusion criteria
Exclusion criteria: EXCLUSION CRITERIA: 1.Any disease or condition which might compromise the hematopoietic, renal, endocrine, Pulmonary, central nervous system, cardiovascular, immunological, dermatological, Gastro- intestinal or any other body system. 2.Persons with colour blindness. 3.Persons who have undergone surgery in last two months. 4.Planned medical / dental treatment during the proving period including herbal or dietary supplements, procedures, or medications that are likely to interfere with, or substantially alter, responsiveness to the proving substance. 5.Volunteers on regular medication (Allopathic, Ayurvedic, Homoeopathic, Naturopathic, Unani, etc.) for any acute or chronic disease. 6.Participant must not be on any homoeopathic remedy in the preceding one month and have had no significant change in health status in last one month. 7.Emotionally disturbed, hysterical or anxious persons. 8.Persons having known history of allergies, food hypersensitivity, etc. 9.Women during pregnancy, puerperium and while breast-feeding and women who have undergone hysterectomy. 10.No Bad Hobbits. 10.Recent history of alcoholism / drug addictions or unlikely to refrain from excessive alcohol consumption / drug intake during the study period 11.Participation in another clinical or proving trial during the last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Identify the effects of Azadirachta indica on the Prover with the help of day book Timepoint: 4weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate human pathogenetic trial effects on both sexes of different ages & various constitutionsTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactDR ANAND PAL SINGH KUSHWAH
BHARTI VIDYAPEETH DEEMED UNIVERSITY HOMEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed